-transparent.png){kind=logo}
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. 1997
Glaxo Wellcome Research and Development, Research Triangle Park, North Carolina 27709, USA. shearer-bg@glaxo.com
S-Ethyl N-phenylisothiourea (4) has been found to be a potent inhibitor of both the human constitutive and inducible isoforms of nitric oxide synthase. A series of substituted N-phenylisothiourea analogues was synthesized to investigate the structure-activity relationship of this class of inhibitor. Each analogue was evaluated for human isoform selectivity. One analogue, S-ethyl N-[4-(trifluoromethyl)phenyl]isothiourea (39), exhibited 115-fold and 29-fold selectivity for the neuronal isoform versus the inducible and endothelial derived constitutive isoforms, respectively. Studies have shown the substituted N-phenylisothiourea 39 binds competitively with L-arginine.
Related Publications
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
January 1995,
British journal of pharmacology,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
August 2017,
Journal of medicinal chemistry,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
January 2003,
Bioorganic & medicinal chemistry letters,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
September 2004,
Bioorganic & medicinal chemistry letters,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
January 2004,
Journal of medicinal chemistry,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
July 2009,
Journal of medicinal chemistry,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
November 2010,
Bioorganic & medicinal chemistry letters,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
January 2010,
Bioorganic & medicinal chemistry letters,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
June 2007,
Bioorganic & medicinal chemistry letters,
B G Shearer, and
S Lee, and
J A Oplinger, and
L W Frick, and
E P Garvey, and
E S Furfine
July 2023,
Journal of medicinal chemistry,
